Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00813501 · ClinicalTrials.gov registry record
Immunologic Diagnostic Blood Test in Predicting Side-Effects in Patients Undergoing a Donor Stem Cell Transplant for Hematologic Cancer or Other Diseases
A clinical trial, sponsored by City of Hope Medical Center.
- Terminated
- Registry status
- 60
- Enrollment target
NCT00813501: Clinical Trial study, sponsored by City of Hope Medical Center.
NCT00813501 is a clinical trial that was terminated before completion, run by City of Hope Medical Center. The registered enrollment target is 60 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00813501 was terminated before completion, sponsored by City of Hope Medical Center.
- TERMINATED
- Registry status
- 60 participants
- Enrollment target
Study Summary
RATIONALE: Studying a diagnostic biomarker test in blood samples from patients who have undergone a donor stem cell transplant for cancer may help doctors plan treatment. PURPOSE: This clinical trial is studying an immunologic diagnostic blood test to see how well it works in predicting side-effects in patients with hematologic cancer or other disorders who have undergone a donor stem cell transplant.
Interventions
- PROCEDURE allogeneic hematopoietic stem cell transplantation
- OTHER immunological diagnostic method
- BIOLOGICAL immunosuppressive therapy
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 60 participants |
| Start Date | 2008-06 |
| Est. Completion | 2010-06 |
Why NCT00813501 stopped before completion
NCT00813501 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 60 participants, a relatively small participant target.
The record links to 0 conditions, and to 3 interventions - of which allogeneic hematopoietic stem cell transplantation is the first listed.
NCT00813501 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00813501 about?
NCT00813501 is a clinical study titled "Immunologic Diagnostic Blood Test in Predicting Side-Effects in Patients Undergoing a Donor Stem Cell Transplant for Hematologic Cancer or Other Diseases". RATIONALE: Studying a diagnostic biomarker test in blood samples from patients who have undergone a donor stem cell transplant for cancer may help doctors plan treatment. PURPOSE: This clinical trial is studying an immunologic diagnostic blood test to see how well it works in predicting side-effect...
What is the current status of trial NCT00813501?
This trial is currently terminated. The enrollment target is 60 participants. The study started on 2008-06. Estimated completion is 2010-06.
What interventions are being tested in trial NCT00813501?
The interventions under investigation include: allogeneic hematopoietic stem cell transplantation (PROCEDURE), immunological diagnostic method (OTHER), immunosuppressive therapy (BIOLOGICAL).
Who is sponsoring clinical trial NCT00813501?
This trial is sponsored by City of Hope Medical Center, which has 582 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00576069 · 60 participants
Mechanism(s)of Airflow Limitation in Moderate-severe Persistent Asthma
- NCT01297400 · 60 participants · Phase 2
Phase 2 Pilot Study of the Safety and Efficacy of Topical MW-III in Thermal Burns
- NCT01734122 · 60 participants
Stereotactic Radiosurgery for Essential Tremor and Parkinsonian Tremor
- NCT01804634 · 60 participants · Phase 2
Reduced Intensity Haploidentical BMT for High Risk Solid Tumors
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia